Medioni, J., Huchon, C., Le Frere-Belda, M., Hofmann, H., Bats, A., Eme, D., . . . Levy, E. (2012). Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors. Springer International Publishing.
Chicago Style aipamenaMedioni, Jacques, et al. Neoadjuvant Dose-Dense Gemcitabine Plus Docetaxel and Vinorelbine Plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors. Springer International Publishing, 2012.
MLA aipamenaMedioni, Jacques, et al. Neoadjuvant Dose-Dense Gemcitabine Plus Docetaxel and Vinorelbine Plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors. Springer International Publishing, 2012.